New eye scans may unlock secrets of glaucoma blindness

NCT ID NCT07580014

Recruiting now Knowledge-focused Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will use advanced eye scans (OCT and OCTA) to compare the structure and blood flow of the choroid and retina in people with two main types of glaucoma: primary angle-closure disease and primary open-angle glaucoma. Researchers aim to better understand how these conditions damage the eye, which could lead to improved diagnosis or treatment. The study will enroll 132 participants, including healthy controls and patients diagnosed with glaucoma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could reveal new details about how glaucoma damages the eye, potentially pointing toward earlier detection or new treatment targets.
What could go wrong: This is an observational study, not a treatment trial. It will not directly benefit participants, and findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOROID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma open-angle glaucoma optic choroid disorder primary angle-closure glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOROID GLAUCOMA OCTA

Contacts and locations

Locations

Zhongshan Ophthalmic Center, Sun Yat-sen University
RECRUITING

Guangzhou, Guangdong, 510060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.